RecruitingPhase 4NCT06569537

Comparison of Compounded Topical Anesthetics

Comparison of Compounded Topical Anesthetics for Pain Relief of Intense Pulsed Light, Pulse Dye Laser, and Microneedling Treatments

Sponsor

Dartmouth-Hitchcock Medical Center

Enrollment

64 participants

Start Date

Oct 22, 2024

Study Type

INTERVENTIONAL

Conditions

Procedural Pain

Summary

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

Men and women over 18, but not more than 75 years of age.
Patients who have a regularly scheduled dermatology appointment for Intense Pulse Light (IPL), Pulse Dye Laser (PDL), or microneedling.

Exclusion Criteria5

Any subject who has a previous history of allergy, sensitivity, and contraindication to benzocaine, lidocaine, or tetracaine.
Patients with cardiac/respiratory disease, seizure disorder, or neuropathies.
Patients who are under treatment for a dermatologic condition that may interfere with the evaluation of the study.
Pregnant women and women who are breastfeeding.
Patients who report concurrent use of anxiolytics or opiates, which may interfere with the interpretation of results.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.